83 related articles for article (PubMed ID: 8816060)
21. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
[TBL] [Abstract][Full Text] [Related]
22. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
23. Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma.
Friedman J; Khoury H; Adkins D; Devine S; Nervi B; Edwards T; Dipersio J; Vij R
Bone Marrow Transplant; 2005 May; 35(10):979-84. PubMed ID: 15806132
[TBL] [Abstract][Full Text] [Related]
24. [Progression of multiple myeloma during treatment with recombinant G-CSF and absence of G-CSF and IL-6 cell surface receptors on malignant cells].
Spicka I; Jirásek A; Koubek K; Cieslar P; Klener P
Cas Lek Cesk; 1998 Nov; 137(21):660-3. PubMed ID: 9929931
[TBL] [Abstract][Full Text] [Related]
25. B cell maturation in relation to multiple myeloma.
Stevenson FK; Sahota SS
Pathol Biol (Paris); 1999 Feb; 47(2):89-97. PubMed ID: 10192875
[TBL] [Abstract][Full Text] [Related]
26. The role of autologous stem cell transplantation in the management of multiple myeloma.
Fermand JP; Brechignac S
Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell transplantation in multiple myeloma.
Pant S; Copelan EA
Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
[TBL] [Abstract][Full Text] [Related]
28. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
Pope B; Brown R; Gibson J; Joshua D
Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
[TBL] [Abstract][Full Text] [Related]
30. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
[TBL] [Abstract][Full Text] [Related]
31. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
[TBL] [Abstract][Full Text] [Related]
32. High-dose therapy in multiple myeloma: effect of positive selection of CD34+ peripheral blood stem cells on hematologic engraftment and clinical outcome.
Patriarca F; Damiani D; Fanin R; Grimaz S; Geromin A; Cerno M; Sperotto A; Silvestri F; Zaja F; Baccarani M
Haematologica; 2000 Mar; 85(3):269-74. PubMed ID: 10702815
[TBL] [Abstract][Full Text] [Related]
33. Intraclonal offspring expansion of gastric low-grade MALT-type lymphoma: evidence for the role of antigen-driven high-affinity mutation in lymphomagenesis.
Qin Y; Greiner A; Hallas C; Haedicke W; Müller-Hermelink HK
Lab Invest; 1997 Apr; 76(4):477-85. PubMed ID: 9111510
[TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
[TBL] [Abstract][Full Text] [Related]
35. Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.
Villunger A; Egle A; Kos M; Hittmair A; Maly K; Greil R
Int J Cancer; 1996 Feb; 65(4):498-505. PubMed ID: 8621234
[TBL] [Abstract][Full Text] [Related]
36. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma.
Vescio RA; Hong CH; Cao J; Kim A; Schiller GJ; Lichtenstein AK; Berenson RJ; Berenson JR
Blood; 1994 Nov; 84(10):3283-90. PubMed ID: 7524734
[TBL] [Abstract][Full Text] [Related]
37. [Advances in biology and pathogenesis of multiple myeloma].
Kosaka M; Abe M; Takishita M; Ozaki S; Goto T
Nihon Rinsho; 1995 Mar; 53(3):627-35. PubMed ID: 7699896
[TBL] [Abstract][Full Text] [Related]
38. Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma.
Chen YH; Shiao RT; Labayog JM; Modi S; Lavelle D
Leuk Lymphoma; 1997 Sep; 27(1-2):11-23. PubMed ID: 9373192
[TBL] [Abstract][Full Text] [Related]
39. Biologic and clinical advances in multiple myeloma.
Varterasian ML
Oncology (Williston Park); 1995 May; 9(5):417-24; discussion 429-30. PubMed ID: 7547203
[TBL] [Abstract][Full Text] [Related]
40. Advances in the biology and treatment of multiple myeloma.
Varterasian ML
Curr Opin Oncol; 1999 Jan; 11(1):3-8. PubMed ID: 9914870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
